New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 26, 2013
20:30 EDTSCMPSucampo receives $10M milestone payment from Takeda
Sucampo Pharmaceuticals announced that it has received a $10M milestone payment from Takeda, pursuant to the existing collaboration and license agreement between SPI and Takeda. The milestone payment was triggered by the commercial launch of AMITIZA in the United States for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain. This is the third indication for AMITIZA.
News For SCMP From The Last 14 Days
Check below for free stories on SCMP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2014
15:12 EDTSCMPSucampo says FDA approves addition of Nitto Medic as Rescula production site
Sucampo Pharmaceuticals disclosed in a regulatory filing that on July 15 the company received an approval letter from the FDA to its prior approval supplement in response to FDAs review of the revised Drug Master File of R-Tech Ueno. The approval provides for the addition of Nitto Medic of Toyama, Japan as a new production site for Rescula 0.15%. "The company has adequate supply of RESCULA to be able to supply the U.S. market into the first quarter of 2015," Sucampo added.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use